NIBEC CO., LTD. Logo

NIBEC CO., LTD.

Biotech CDMO creating regenerative products with peptide and biomaterial technologies.

138610 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 진천군 이월면 밤디길 116 이월전기전자농공1단지, 진천군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NIBEC Co., Ltd. is a biotechnology company focused on developing innovative healthcare solutions through regenerative medicine. The company specializes in the research, development, and commercialization of products based on its core expertise in bioactive peptide technology and advanced biomaterials. Its primary offerings include tissue regenerative products, such as dental bone grafts and collagen-based materials, as well as peptide-based smart materials and bio-fusion products for medical applications. Additionally, NIBEC operates as a Contract Development and Manufacturing Organization (CDMO), providing cGMP-compliant custom peptide synthesis and manufacturing services to the pharmaceutical and biotech sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-05 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 903.3 KB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-04 00:00
Share Issue/Capital Change
전환청구권행사
Korean 11.5 KB
2025-05-28 00:00
M&A Activity
투자판단관련주요경영사항 (NP201 기술이전의 건)
Korean 13.8 KB
2025-05-22 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.1 KB
2025-05-22 00:00
Share Issue/Capital Change
전환가액의조정
Korean 12.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 815.7 KB
2025-04-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.2 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 993.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.1 KB
2025-03-20 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 21.2 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 101.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 92.6 KB

Automate Your Workflow. Get a real-time feed of all NIBEC CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NIBEC CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.